Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-051239

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Topper James N Director 2022-09-22 Grant or award · Stock Option (Right to Buy +20,000 20,000 D
Loading xslF345X03/doc4.xml…